Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Seisha Alana Von Glasenapp, Maria Elvira Enciso Arrua, Alfredo Quiroz, Aline Nicole Paats, Laura Morel, Leticia Rocio Jiménez, Lidiane Andino, Victor Ladislao Salinas, Bryan Valcarcel, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 6217.

https://doi.org/10.1182/blood-2023-186387

Published: 2023

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial

Blood (2023) 142 (Supplement 1): 3036.

https://doi.org/10.1182/blood-2023-181216

Published: 2023

Journal Articles

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study

Blood (2023) 142 (Supplement 1): 3079.

https://doi.org/10.1182/blood-2023-180318

Published: 2023

Journal Articles

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Thais Fischer, Henry Idrobo, Astrid Pavlovsky, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela, Juliana Pereira, Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson Castro, Renata Baptista, Samuel de S Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leao Cordeiro De Farias, Yung Bruno Gonzaga, Fernando Warley, Lorena Fiad, Laura Korin, Patricio Hernan Pereyra, Camila Peña, Maria Alejandra Torres, Carolina Valeria Mahuad, Alana Von Glasenapp, Alfredo Reinaldo Quiroz, Raimundo Gazitua, Cesar Augusto Samanez-Figari, Lautaro Sardu, Juan Pablo Arriola, Sebastian Isnardi, Juan L. Maradei, Raul Hector Gabus, Alicia I. Enrico, Luciana A Guanchiale, Florencia Negri Arangueren, Juan Ignacio García Altuve, Amalia Cerutti, Romina Penalva, Jose Ignacio Garcia Trucco, Florencia Pessolani, Virginia Gilli, Joaquin Diaz, Maria Enriqueta Martinez, Gustavo Jarchum, Gabriela Celia Perinotto, Teresa Barraza, Sergio Ciarlo, Christine Rojas, Rosa Oliday Rios Jiménez, Carmino De Souza, Martina Manni, Eliana C M CM Miranda, Massimo Federico, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 186.

https://doi.org/10.1182/blood-2023-187254

Published: 2023

Journal Articles

Clinical Features, Treatment Patterns and Outcomes of 864 Newly Diagnosed Hodgkin Lymphoma Patients in Latin America and the Impact of PET Scan Availability on Survival: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 4441.

https://doi.org/10.1182/blood-2023-185131

Published: 2023

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Rafael Martin De Jesus Pichardo Rodriguez, Brady E Beltran, Luis Vilela, Marialejandra Torres Viera, Jhony A. De La Cruz-Vargas, Oscar Ruiz-Franco, Jorge J. Castillo, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2023-185194

Published: 2023

Journal Articles

Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions

Bryan Valcarcel, Haruhiko Sano, Hiroo Katsuya, Atae Utsunomiya, Maki Otsuka, Masaharu Miyahara, Yasushi Takamatsu, Kenji Ishitsuka, Shinya Kimura, Junji Suzumiya, Kazuo Tamura, Daniel J Enriquez, Denisse Castro, Brady E Beltran, Henry Idrobo, Camila Peña, Lorena Fiad, Juan Carlos Ramos, Luis Enrique Malpica Castillo

Blood (2022) 140 (Supplement 1): 1072–1073.

https://doi.org/10.1182/blood-2022-168334

Published: 2022

Journal Articles

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Blood (2022) 140 (Supplement 1): 12005–12007.

https://doi.org/10.1182/blood-2022-170750

Published: 2022

Journal Articles

Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment Responses in Patients (pts) with Mantle Cell Lymphoma

Blood (2022) 140 (Supplement 1): 3598–3600.

https://doi.org/10.1182/blood-2022-162806

Published: 2022

Journal Articles

Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy

Andrew Jallouk, Lei Feng, Mansoor Noorani, Kaberi Das, Raphael E Steiner, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Jason Westin, Luis Fayad, Dai Chihara, Luis Enrique Malpica Castillo, Swaminathan P. Iyer, Sairah Ahmed, Elizabeth J Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati

Blood (2022) 140 (Supplement 1): 10424–10426.

https://doi.org/10.1182/blood-2022-166783

Published: 2022

Journal Articles

Prognostic Significance of Cutaneous Angioimmunoblastic T-Cell Lymphoma: Correlation of Clinical, Histologic and Immunophenotypic Features with Response

Christopher N Nguyen, Rishab Prakash, Madeleine Duvic, Meghan Heberton, Julia Dai, Ranjit Nair, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Lei Feng, Swaminathan Padmanabhan Iyer, Auris Huen

Blood (2022) 140 (Supplement 1): 9406–9407.

https://doi.org/10.1182/blood-2022-163810

Published: 2022

Journal Articles

Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis

Blood (2022) 140 (Supplement 1): 6664–6665.

https://doi.org/10.1182/blood-2022-168101

Published: 2022

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6697–6698.

https://doi.org/10.1182/blood-2022-162389

Published: 2022

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin

Alexandra Elias, Rishab Prakash, Loretta J. Nastoupil, Nathan H. Fowler, Sairah Ahmed, Ranjit Nair, Luis Enrique Malpica Castillo, Bouthaina S. Dabaja, Jie Xu, Jeffrey Medeiros, John Stewart, Wei Wang, Chelsea C. Pinnix, Kelly Hunt, Mark W Clemens, Roberto N. Miranda, Swaminathan P. Iyer

Blood (2022) 140 (Supplement 1): 3721–3723.

https://doi.org/10.1182/blood-2022-170845

Published: 2022

NARROW

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Clinical Features, Treatment Patterns and Outcomes of 864 Newly Diagnosed Hodgkin Lymphoma Patients in Latin America and the Impact of PET Scan Availability on Survival: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment Responses in Patients (pts) with Mantle Cell Lymphoma

Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy

Prognostic Significance of Cutaneous Angioimmunoblastic T-Cell Lymphoma: Correlation of Clinical, Histologic and Immunophenotypic Features with Response

Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only